T/CAPC 012-2023
Standards for pharmaceutical care of retail pharmacies supplying diabetes, hypertension and dyslipidemia medications (English Version)

Standard No.
T/CAPC 012-2023
Language
Chinese, Available in English version
Release Date
2023
Published By
Group Standards of the People's Republic of China
Latest
T/CAPC 012-2023
Scope
Retail pharmacies should fully understand that my country's "three highs" are the three main risk factors for cardiovascular disease morbidity and death. Based on the characteristics of my country's "three highs" with a large number of patients and low control rates, retail pharmacies should give full play to the role of retail pharmacies in chronic disease management. The role of the hospital is to provide standardized, continuous, and full-course pharmaceutical services for patients with “three highs”. Through the collection of patient information, assessment and intervention, medication guidance, patient education, home follow-up, and file establishment, we can improve patients’ correct understanding of the disease and medication compliance, improve patients’ self-management capabilities and develop good living habits, and reduce the “three highs” "The patient's overall risk of cardiac, cerebral, renal and vascular complications and death is improved, and their quality of life is improved.

T/CAPC 012-2023 history

  • 2023 T/CAPC 012-2023 Standards for pharmaceutical care of retail pharmacies supplying diabetes, hypertension and dyslipidemia medications



Copyright ©2024 All Rights Reserved